- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insight 3651 results
Newsletter
September 16, 2021
Data, Privacy & Security Practice Report – September 2021
Client Alert
September 14, 2021
Executive Orders Requiring New Safety Protocols Against COVID-19 for Federal Contractors and COVID-19 Vaccination Requirements for Federal Employees
Client Alert
September 13, 2021
U.S. EPA and CalEPA Launch Joint Effort to Strengthen Enforcement in Environmental Justice Communities
Thought Leadership
September 13, 2021
Amy Peters Joins Leaders in the Private Debt Industry for a Roundtable Discussion
Thought Leadership
September 9, 2021
Heather Banuelos Joins the Program Committee for DIA’s 2022 Advertising and Promotion Regulatory Affairs Conference
Newsletter
September 7, 2021
Health Headlines – September 7, 2021
Client Alert
September 7, 2021
EPA Extends Compliance Dates for PBT PIP (3:1)
Article · Source: Pratt’s Journal of Bankruptcy Law
September 1, 2021
Not in My Court: Texas Bankruptcy Judge Dismisses NRA Bankruptcy Cases As Filed in Bad Faith
Article · Source: Intellectual Property & Technology Law Journal
September 1, 2021
“Purple Book” Patent Listing Under Biological Product Patent Transparency Act: What Is Required, and What to Expect?
Client Alert
August 31, 2021
Decentralized Finance—Risks, Regulation, and the Road Ahead
Client Alert
August 31, 2021
EPA Submitted Proposed Renewable Fuel Standards to OMB
Newsletter
August 31, 2021
Predominant Issues – August 2021